Replicative senescence in organ transplantation - Mechanisms and significance

Transplant Immunology

Volumn 9, Issue 2-4, 2002, Pages 165-171

  Chkhotua, A ^a,b   Shohat, M ^b   Tobar, A ^b   Magal, N ^b   Kaganovski, E ^b   Shapira, Z ^b   Yussim, A ^b,c  

^a Institute for High Energy Physics   (Georgia)

^b TEL AVIV UNIVERSITY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

Ischemia; Kidney; Mechanism; Senescence; Transplantation

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; BETA GALACTOSIDASE; CYCLOSPORIN A; CYTOSTATIC AGENT; ENZYME; GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; LIPOFUSCIN; SENESCENCE ASSOCIATED BETA GALACTOSIDASE; TACROLIMUS; UNCLASSIFIED DRUG;

AGE; ALLOGRAFT; BIOLOGICAL RHYTHM; CELL DENSITY; CELL DIVISION; CELL FUNCTION; CONFERENCE PAPER; CORRELATION FUNCTION; DETERIORATION; DISEASE MARKER; DOSE RESPONSE; DRUG CYTOTOXICITY; ENVIRONMENTAL FACTOR; GENETIC REGULATION; GRAFT SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LIFESPAN; MITOSIS INHIBITION; NEPHROTOXICITY; NONHUMAN; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REPERFUSION; REPERFUSION INJURY; SENESCENCE; STRESS; SURVIVAL RATE; TELOMERE; VALIDATION PROCESS; ANIMAL; CELL AGING; DRUG EFFECT; KIDNEY; PATHOLOGY; PHYSIOLOGY; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL AGING; GENES, P16; GENES, P53; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; TELOMERE;

EID: 0036580377     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(02)00003-5     Document Type: Conference Paper

References (67)

1. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection
2. Determinants of pancreatic islet cell mass: A balance between neogenesis and senescence/apoptosis
3. Aging and the kidney
4. Changes with age in the human kidney
5. Longitudinal studies on the rate of decline in renal function with age
6. A multifactor analysis of kidney graft outcomes at 1 and 5 years posttransplantation: 1996 UNOS update
7. Rethinking chronic allograft nephropathy: The concept of accelerated senescence
8. Specific association of human telomerase activity with immortal cells and cancer
9. The aging kidney
10. The limited in vitro lifetime of human diploid cell strains
11. The biology of replicative senescence
12. Telomerase and cellular lifespan: Ending the debate?
13. Extension of lifespan by introduction of telomerase into normal human cells
14. Increased activity of p53 in senescing fibroblasts
15. Involvement of cycline dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts
16. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts
17. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes
18. Telomere shortening is associated well with cell division in vitro and in vivo
19. Examination of telomere length in muscle tissue casts doubt on replicative aging as cause of progression in Duchenne muscular dystrophy
20. Telomere shortening in kidneys with age
21. Escape from senescence in human diploid fibroblasts induced directly by mutant p53
22. Alterations in p53 and p16ink4 expression and telomere length during spontaneous immortalisation of Li-Fraumeni syndrome fibroblasts
23. Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence
24. Cellular senescence and cancer
25. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
26. Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti p53 antibodies
27. Regulation of p16 CDKN2 expression and its implications for cell immortalisation and senescence
28. Induction of senescence in human malignant glioma cell by p16 INK4a
29. Agents that cause DNA double strand breaks lead to p16 INK4a enrichment and the premature senescence of normal fibroblasts
30. Reexpression of retinoblastoma protein in tumor cells induces senescence and telomerase inhibition
31. Telomere length in fibroblasts and blood cells from healthy centerians
32. Inactivation of p16 in human mammary epithelial cells by CpG island methilation
33. Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres
34. The influence of cell context on the selection pressure for p53 mutation in human cancer
35. Apoptosis in human papilomavirus 16 E7 - but not E6 - Immortalized human uroepithelial cells
36. Cellular senescence in telomerase-expressing Syrian hamster embryo cells
37. Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells
38. Primary culture of proximal tubular cells from normal rat kidney as an in vitro model to study mechanisms of nephrotoxicity. Toxicity of nephrotoxins at low concentrations during prolonged exposure
39. Primary culture of rabbit proximal tubules as a cellular model to study nephrotoxicity of xenobiotics
40. Toxicity of cyclophosphamide and their metabolites in renal tubular cells in culture
41. Differential actions of cisplatin on renal proximal tubule and inner medullary collecting duct cells
42. Effect of cyclosporin A on endothelin synthesis by cultured human renal cortical epithelial cells
43. Cyclosporin A and vehicle toxicity in primary cultures of rabbit renal proximal tubular cells
44. Acute effects of FK 506 and cyclosporin A on cultured human proximal tubular cells
45. An animal model of chronic cyclosporine nephrotoxicity
46. Acute cyclosporine A-induced nephrotoxicity: A rabbit model
47. Cyclosporine A induced alterations in magnesium homeostasis in the rat
48. Effects of cyclosporine A on the synthesis, excretion and metabolism of endothelin in the rat
49. Chronic cyclosporine-induced nephropathy in the rat. A medullary ray and inner stripe injury
50. Sodium depletion enhances fibrosis and the excretion of TGF-1 and matrix proteins in experimental chronic cyclosporine nephrotoxicity
51. Role of intrarenal endothelin 1, endothelin 3 and angiotenzin II expression in chronic cyclosporin A nephrotoxicity in rats
52. Direct effect of chronic cyclosporine treatment on collagen III mRNA expression and deposition in rat kidneys
53. Quinacrine attenuates cyclosporine-induced nephrotoxicity in rats
54. Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model
55. Chronic cyclosporine nephrotoxicity
56. FK 506-induced kidney tubular cell injury
57. Structure-activity relationships of cyclosporines. Toxicity in cultured renal tubular epithelial cells
58. Apoptosis and necrosis: Mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line
59. Acute inhibition of human renal tubular cell growth by cyclosporin A
60. Insights into cyclosporine nephrotoxicity
61. Cyclosporine nephropathy: Pathophysiology and clinical impact
62. Cyclosporine A-induced cell cycle arrest and cell death in renal epithelial cells
63. Cellular senescence: A new marker of kidney function recovery after ischemic injury in rats
64. Cellular senescence: Mitotic clock or culture shock?
65. Renal senescence reflects different mechanisms in human and rodent kidneys
66. Cell senescence and its implication for nephrology